Phio Pharmaceuticals(PHIO)

招股说明书

Phio Pharmaceuticals(PHIO)07-27 04:35

$Phio Pharmaceuticals(PHIO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-005092  Act: 33  Size: 586 KB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)05-10 05:25

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-24-003178  Act: 34  Size: 245 KB 网页链接查看全文

持股变动声明

Phio Pharmaceuticals(PHIO)06-12 05:05

$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004126  Size: 4 KB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)07-03 05:05

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001683168-24-004619  Act: 34  Size: 245 KB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)07-05 20:05

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.02, 8.01, and 9.01 Accession Number: 0001683168-24-004683  Act: 34  Size: 211 KB 网页链接查看全文

招股说明书

Phio Pharmaceuticals(PHIO)05-17 21:15

$Phio Pharmaceuticals(PHIO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001683168-24-003600  Act: 33  Size: 370 KB 网页链接查看全文

生效批准

Phio Pharmaceuticals(PHIO)07-02 18:05

$Phio Pharmaceuticals(PHIO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002034  Act: 33  Size: 1 KB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)07-25 04:35

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 8.01 Accession Number: 0001683168-24-005049  Act: 34  Size: 198 KB 网页链接查看全文

其他

Phio Pharmaceuticals(PHIO)05-09 05:05

$Phio Pharmaceuticals(PHIO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001683168-24-003114  Act: 34  Size: 480 KB 网页链接查看全文

当期报告

Phio Pharmaceuticals(PHIO)05-29 05:05

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-24-003849  Act: 34  Size: 218 KB 网页链接查看全文

只抄右侧底2023-10-11 23:33

$Phio Pharmaceuticals(PHIO)$ $Tempest Therapeutics(TPST)$ 模仿秀。居然在2.2加仓还能2.5出来我也是醉了，再进$Blue Star Foods(BSFC)$ ,既然是玩垃圾股那就一个个玩过来。这个才5500股大家看看就好，不建议乱来。查看全文

产业链观察2023-02-10 21:56

#药闻简讯# 2023年2月10日，临床阶段生物技术公司$Phio Pharmaceuticals(PHIO)$ 今天宣布，一个独立的数据监测委员会 (DMC) 完成了对公司用于治疗晚期黑色素瘤的 PH-762 1b 期临床试验的中期安全数据的预指定审查。该试验正在欧洲最大的癌症中心之一Gustave Roussy研究所（法国Villejuif）进行。PH...查看全文

牛唐2022-04-14 11:31

$Phio Pharmaceuticals(PHIO)半个月，150%+的收益。$百度(BIDU)$ $叮咚买菜(DDL)$ $理想汽车(LI)$查看全文

牛唐2022-04-13 21:24

$Phio Pharmaceuticals(PHIO)$ 150%+的收益。$蔚来(NIO)$ $阿里巴巴(BABA)$查看全文

牛唐2021-04-13 17:17

$Phio Pharmaceuticals(PHIO)$ 虎口夺食。$哔哩哔哩(BILI)$ $快手-W(01024)$查看全文

牛唐2021-04-13 12:13

医药板块观察（2021.04.12）
本期内容提示：
1、一大波核心仓位出现建仓机会，优先考虑哪些？
2、又一只有翻倍潜力的成长股临近理想建仓区；
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错，可否追涨？
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文

似云似水2021-03-11 21:25

$Phio Pharmaceuticals(PHIO)$ 有点意思了 开盘后但愿能挺住查看全文

Replix锐璞美股2021-03-01 21:16

$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文

晚安海绵宝宝2021-02-18 16:34

$Phio Pharmaceuticals(PHIO)$看个7不过分吧查看全文

Replix锐璞美股2021-02-18 14:08

$Phio Pharmaceuticals(PHIO)$ 公司增发完毕，看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文

招股说明书

$Phio Pharmaceuticals(PHIO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-005092  Act: 33  Size: 586 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 8.01 Accession Number: 0001683168-24-005049  Act: 34  Size: 198 KB 网页链接

发行公告

$Phio Pharmaceuticals(PHIO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001123292-24-000200  Act: 33  Size: 10 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001683168-24-004800  Act: 34  Size: 593 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.02, 8.01, and 9.01 Accession Number: 0001683168-24-004683  Act: 34  Size: 211 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001683168-24-004619  Act: 34  Size: 245 KB 网页链接

生效批准

$Phio Pharmaceuticals(PHIO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002034  Act: 33  Size: 1 KB 网页链接

当期报告

$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001683168-24-004417  Act: 34  Size: 397 KB 网页链接

持股变动声明

$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004126  Size: 4 KB 网页链接

持股变动声明

$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004089  Size: 4 KB 网页链接